Azelaic acid esters in the treatment of insulin resistance
AssigneeNew Frontier Labs, LLC
InventorsRobert T. STREEPER, Elzbieta IZBICKA
Life of this patent
Estimating the term…
Abstract
A method of treating insulin resistance includes administering to a subject a pharmaceutical composition comprising diethyl azelate. For example, a method of treating insulin resistance includes orally administering to a subject a pharmaceutical composition that includes diethyl azelate at a dosage range from about 0.1 mg/kg/day to about 10 mg/kg/day.
Claims20
A method of treating insulin resistance comprising administering to a subject a pharmaceutical composition comprising diethyl azelate.
A method of treating insulin resistance comprising orally administering to a subject a pharmaceutical composition comprising diethyl azelate at a dosage range from about 0.5 mg/kg/day to about 5 mg/kg/day.
Dependencies are inferred from the claim text.